Consensus Report

NMN & NAD+

2.3

Split Consensus

out of 5

Based on 29 videos (52 hours analyzed) across 5 experts · Updated 2026-03-19

Expert Positions

Andrew Huberman
Andrew Huberman
Takes It, But Not for Longevity
Peter Attia
Peter Attia
Categorizes as 'Noise'
Rhonda Patrick
Rhonda Patrick
Promising but Unproven in Humans
Bryan Johnson
Bryan Johnson
No Direct Coverage
Mark Hyman
Mark Hyman
Advocates for NAD Precursors

The Verdict

This is one of the most divisive topics among our 5 experts. Attia categorizes NAD supplementation as 'noise' on his evidence hierarchy, while Hyman actively advocates for NAD precursors as part of a longevity stack. Huberman personally takes NR and NMN for subjective energy but explicitly not for longevity. Patrick provides the most balanced scientific coverage, noting promising animal data but significant gaps in human evidence.

Unlock the Full Report

Get dosages, timing protocols, expert deep dives with video citations, and risks for NMN & NAD+.

$9/month or $79/year · Cancel anytime